ESC 365 - Risk stratification for a primary prevention ICD: Performance of the MADIT-ICD Benefit Score in contemporary real world patients

ESC2024 Premium Access

Risk stratification for a primary prevention ICD: Performance of the MADIT-ICD Benefit Score in contemporary real world patients

Session: 'Shocking' news on implantable cardioverter defibrillators

Topic: Device Treatment

Speaker: Mr D. Dzikowicz (Rochester, US)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Mr Dillon J Dzikowicz

University of Rochester, Rochester (United States of America)

0 follower

5 more presentations in this session

Insights from an international clinic survey on CIED patient management practices and perceptions

Speaker: Doctor E. Martens (Munich, DE)

Comparison of ICD implantation approach in children. The IChilDren study.

Speaker: Professor V. Probst (Nantes, FR)

Risk for appropriate ICD intervention and complications in patients implanted after an out-hospital cardiac arrest compared to patients implanted for primary and other secondary prevention indication

Speaker: Doctor E. Baldi (Pavia, IT)

Incidence of systolic heart failure and need for implantable cardiac defibrillators in patients with atrial fibrillation who had catheter ablation versus antiarrhythmic medical therapy

Speaker: Doctor B. Ali (Cleveland, US)

Similar incidence of ICD-shocks in diabetic compared to non-diabetic patients receiving implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D)

Speaker: Doctor S. Haxha (Hilleroed, DK)

Access the full session

'Shocking' news on implantable cardioverter defibrillators

Speakers: Mr D. Dzikowicz, Doctor E. Martens, Professor V. Probst, Doctor E. Baldi, Doctor B. Ali...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources